Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin

Michelle A. Hladunewich, Dan Cattran, Sanjeev M. Sethi, Salim S. Hayek, Jing Li, Changli Wei, Sarah I. Mullin, Heather N. Reich, Jochen Reiser, Fernando C. Fervenza

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin'. Together they form a unique fingerprint.

Medicine & Life Sciences